Skip to main content
. Author manuscript; available in PMC: 2020 Jul 7.
Published in final edited form as: J Rheumatol. 2019 Jan 15;46(5):492–500. doi: 10.3899/jrheum.180713

Figure 2. Serum osteopontin (OPN) levels in patients with raised versus low/no disease activity.

Figure 2.

Patients with a SLEDAI-2K score of less than 5 had higher baseline levels of OPN (mean 56.8 ng/ml, n=132) than patients with SLEDAI-2K<5 (mean 38.5 ng/ml, n=213).